TouchNEUROLOGY recently spoke with Gregory Branigan (University of Arizona, US), about the impact of estrogen therapies on Alzheimer’s disease (AD) pathways. The interview was filmed at the American Academy of Neurology Virtual Annual Meeting 2021, held online between 17 and 22 April 2021, and was published online on 10 May 2021. You can watch it, here:
